Generated by DeepSeek V3.2| Virginijus Šikšnys | |
|---|---|
| Name | Virginijus Šikšnys |
| Birth date | 15 November 1956 |
| Birth place | Vilnius, Lithuanian SSR, Soviet Union |
| Nationality | Lithuanian |
| Fields | Biochemistry, Molecular biology |
| Workplaces | Vilnius University, Institute of Biotechnology, Vilnius University |
| Alma mater | Vilnius University |
| Known for | CRISPR-Cas9 research |
| Awards | Kavli Prize in Nanoscience (2018), Warren Alpert Foundation Prize (2017), Japan Prize (2023) |
Virginijus Šikšnys is a Lithuanian biochemist and molecular biologist renowned for his pioneering research on the CRISPR-Cas9 gene editing system. His independent work, published concurrently with that of Emmanuelle Charpentier and Jennifer Doudna, was crucial in demonstrating the programmable nature of the system for cutting DNA. Šikšnys's contributions have positioned him as a key figure in the CRISPR revolution, earning him several of the world's most prestigious scientific awards.
Virginijus Šikšnys was born in Vilnius, then part of the Lithuanian SSR within the Soviet Union. He developed an early interest in the natural sciences, which led him to pursue higher education at Vilnius University, the oldest and largest university in the Baltic states. At the university's Faculty of Chemistry, he earned his Master of Science degree before completing his Doctor of Science in biochemistry. His doctoral research, conducted under the guidance of prominent Lithuanian scientists, focused on restriction enzymes, which are proteins that cut DNA at specific sequences, laying a foundational knowledge for his future groundbreaking work.
Following his doctorate, Šikšnys began his professional research career at the Institute of Biotechnology at Vilnius University, where he has spent the majority of his career. He rose through the academic ranks, eventually becoming the head of the Department of Protein-DNA Interactions. His early research program extensively studied various DNA-modifying enzymes from bacteria, including restriction-modification systems. This expertise in bacterial immunity mechanisms naturally steered his laboratory toward investigating the then-emerging field of CRISPR-Cas systems, which were initially identified as a peculiar genetic feature in archaea and bacteria.
In 2011, Šikšnys and his team at the Institute of Biotechnology made a decisive leap by successfully reconstituting the Streptococcus pyogenes CRISPR-Cas9 system in a test tube. They demonstrated that the system's components—the Cas9 protein and a specifically designed guide RNA—could be programmed to cleave any matching DNA sequence in vitro. Šikšnys submitted his seminal paper detailing these findings to the journal *Cell* in April 2012. Although initially rejected, a revised version was published in the *Proceedings of the National Academy of Sciences* in September 2012, appearing almost simultaneously with the landmark paper by Emmanuelle Charpentier and Jennifer Doudna in *Science*. This work provided the essential biochemical proof that CRISPR-Cas9 could be harnessed as a universal tool for genome editing.
For his foundational role in elucidating the CRISPR-Cas9 mechanism, Virginijus Šikšnys has received numerous international accolades. In 2017, he shared the Warren Alpert Foundation Prize with Emmanuelle Charpentier, Jennifer Doudna, Feng Zhang, and Philipp Horvath. The following year, he was a co-recipient of the prestigious Kavli Prize in Nanoscience alongside Charpentier, Doudna, and Feng Zhang. In 2023, his contributions were further honored with the Japan Prize in the field of Life Science. He is also an elected member of the Lithuanian Academy of Sciences and has been recognized by the European Patent Office with the European Inventor Award.
Virginijus Šikšnys maintains a relatively private personal life. He continues to live and work in Vilnius, where he is a professor and leads his research group at the Institute of Biotechnology. He is known within the scientific community for his modest demeanor and dedicated mentorship of young scientists in Lithuania. His work has significantly elevated the profile of Lithuanian science on the global stage, inspiring a new generation of researchers in the Baltic states.
Category:Lithuanian biochemists Category:Lithuanian molecular biologists Category:CRISPR researchers Category:Recipients of the Japan Prize Category:Kavli Prize laureates Category:Vilnius University alumni Category:Vilnius University faculty Category:1956 births Category:Living people